Cardiovascular adaptations to anemia and the vascular endothelium in sickle cell disease pathophysiology

Lydia Pecker, Hans C. Ackerman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The vascular endothelium is a heterogenous collection of cells whose actions contribute significantly to sickle cell disease pathophysiology. At the cellular level, the endothelium elaborates vasoactive, adhesive, and inflammatory signals that drive acute and chronic injury causing ultimately irreversible organ damage. The endothelium is also fundamentally involved in the cardiovascular adaptations to anemia. Vasodilation lowers systemic vascular resistance and allows higher cardiac output to maintain oxygen transport in an anemic state. Cardiovascular adaptations to anemia and hypoxia may play a role in the pathogenesis of sickle cell disease. Some measures of endothelium-dependent vasodilation appear to be impaired in people with sickle cell disease, but this may be due in part to the effects of chronic anemia. Endothelium-derived vasoactive molecules, such as endothelin-1 and nitric oxide, appear dysregulated and may also contribute to the vascular complications of sickle cell disease. The therapeutic potential of pharmacologically manipulating these molecules has not yet been achieved; however, evidence from patients treated with hydroxyurea and hematopoietic stem cell transplant shows that although it may be difficult to reverse pre-existing injury, effective therapies for sickle cell disease do change endothelial behavior. Ongoing investigations will determine how best to exploit our understanding of endothelial biology and pathobiology to develop new treatments for people with sickle cell disease.

Original languageEnglish (US)
Title of host publicationSickle Cell Anemia
Subtitle of host publicationFrom Basic Science to Clinical Practice
PublisherSpringer International Publishing
Pages129-176
Number of pages48
ISBN (Electronic)9783319067131
ISBN (Print)9783319067124
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Vascular Endothelium
Sickle Cell Anemia
Anemia
Endothelium
Vasodilation
High Cardiac Output
Transplants
Molecules
Hydroxyurea
Wounds and Injuries
Endothelin-1
Hematopoietic Stem Cells
Stem cells
Vascular Resistance
Adhesives
Blood Vessels
Nitric Oxide
Therapeutics
Oxygen

Keywords

  • Adhesion
  • Anemia
  • Blood pressure
  • Vascular endothelium
  • Vascular smooth muscle

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Pecker, L., & Ackerman, H. C. (2016). Cardiovascular adaptations to anemia and the vascular endothelium in sickle cell disease pathophysiology. In Sickle Cell Anemia: From Basic Science to Clinical Practice (pp. 129-176). Springer International Publishing. https://doi.org/10.1007/978-3-319-06713-1_7

Cardiovascular adaptations to anemia and the vascular endothelium in sickle cell disease pathophysiology. / Pecker, Lydia; Ackerman, Hans C.

Sickle Cell Anemia: From Basic Science to Clinical Practice. Springer International Publishing, 2016. p. 129-176.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pecker, L & Ackerman, HC 2016, Cardiovascular adaptations to anemia and the vascular endothelium in sickle cell disease pathophysiology. in Sickle Cell Anemia: From Basic Science to Clinical Practice. Springer International Publishing, pp. 129-176. https://doi.org/10.1007/978-3-319-06713-1_7
Pecker L, Ackerman HC. Cardiovascular adaptations to anemia and the vascular endothelium in sickle cell disease pathophysiology. In Sickle Cell Anemia: From Basic Science to Clinical Practice. Springer International Publishing. 2016. p. 129-176 https://doi.org/10.1007/978-3-319-06713-1_7
Pecker, Lydia ; Ackerman, Hans C. / Cardiovascular adaptations to anemia and the vascular endothelium in sickle cell disease pathophysiology. Sickle Cell Anemia: From Basic Science to Clinical Practice. Springer International Publishing, 2016. pp. 129-176
@inbook{6c01f92b338f44babdbec89b4003c00a,
title = "Cardiovascular adaptations to anemia and the vascular endothelium in sickle cell disease pathophysiology",
abstract = "The vascular endothelium is a heterogenous collection of cells whose actions contribute significantly to sickle cell disease pathophysiology. At the cellular level, the endothelium elaborates vasoactive, adhesive, and inflammatory signals that drive acute and chronic injury causing ultimately irreversible organ damage. The endothelium is also fundamentally involved in the cardiovascular adaptations to anemia. Vasodilation lowers systemic vascular resistance and allows higher cardiac output to maintain oxygen transport in an anemic state. Cardiovascular adaptations to anemia and hypoxia may play a role in the pathogenesis of sickle cell disease. Some measures of endothelium-dependent vasodilation appear to be impaired in people with sickle cell disease, but this may be due in part to the effects of chronic anemia. Endothelium-derived vasoactive molecules, such as endothelin-1 and nitric oxide, appear dysregulated and may also contribute to the vascular complications of sickle cell disease. The therapeutic potential of pharmacologically manipulating these molecules has not yet been achieved; however, evidence from patients treated with hydroxyurea and hematopoietic stem cell transplant shows that although it may be difficult to reverse pre-existing injury, effective therapies for sickle cell disease do change endothelial behavior. Ongoing investigations will determine how best to exploit our understanding of endothelial biology and pathobiology to develop new treatments for people with sickle cell disease.",
keywords = "Adhesion, Anemia, Blood pressure, Vascular endothelium, Vascular smooth muscle",
author = "Lydia Pecker and Ackerman, {Hans C.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-06713-1_7",
language = "English (US)",
isbn = "9783319067124",
pages = "129--176",
booktitle = "Sickle Cell Anemia",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Cardiovascular adaptations to anemia and the vascular endothelium in sickle cell disease pathophysiology

AU - Pecker, Lydia

AU - Ackerman, Hans C.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The vascular endothelium is a heterogenous collection of cells whose actions contribute significantly to sickle cell disease pathophysiology. At the cellular level, the endothelium elaborates vasoactive, adhesive, and inflammatory signals that drive acute and chronic injury causing ultimately irreversible organ damage. The endothelium is also fundamentally involved in the cardiovascular adaptations to anemia. Vasodilation lowers systemic vascular resistance and allows higher cardiac output to maintain oxygen transport in an anemic state. Cardiovascular adaptations to anemia and hypoxia may play a role in the pathogenesis of sickle cell disease. Some measures of endothelium-dependent vasodilation appear to be impaired in people with sickle cell disease, but this may be due in part to the effects of chronic anemia. Endothelium-derived vasoactive molecules, such as endothelin-1 and nitric oxide, appear dysregulated and may also contribute to the vascular complications of sickle cell disease. The therapeutic potential of pharmacologically manipulating these molecules has not yet been achieved; however, evidence from patients treated with hydroxyurea and hematopoietic stem cell transplant shows that although it may be difficult to reverse pre-existing injury, effective therapies for sickle cell disease do change endothelial behavior. Ongoing investigations will determine how best to exploit our understanding of endothelial biology and pathobiology to develop new treatments for people with sickle cell disease.

AB - The vascular endothelium is a heterogenous collection of cells whose actions contribute significantly to sickle cell disease pathophysiology. At the cellular level, the endothelium elaborates vasoactive, adhesive, and inflammatory signals that drive acute and chronic injury causing ultimately irreversible organ damage. The endothelium is also fundamentally involved in the cardiovascular adaptations to anemia. Vasodilation lowers systemic vascular resistance and allows higher cardiac output to maintain oxygen transport in an anemic state. Cardiovascular adaptations to anemia and hypoxia may play a role in the pathogenesis of sickle cell disease. Some measures of endothelium-dependent vasodilation appear to be impaired in people with sickle cell disease, but this may be due in part to the effects of chronic anemia. Endothelium-derived vasoactive molecules, such as endothelin-1 and nitric oxide, appear dysregulated and may also contribute to the vascular complications of sickle cell disease. The therapeutic potential of pharmacologically manipulating these molecules has not yet been achieved; however, evidence from patients treated with hydroxyurea and hematopoietic stem cell transplant shows that although it may be difficult to reverse pre-existing injury, effective therapies for sickle cell disease do change endothelial behavior. Ongoing investigations will determine how best to exploit our understanding of endothelial biology and pathobiology to develop new treatments for people with sickle cell disease.

KW - Adhesion

KW - Anemia

KW - Blood pressure

KW - Vascular endothelium

KW - Vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=85032070654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032070654&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-06713-1_7

DO - 10.1007/978-3-319-06713-1_7

M3 - Chapter

SN - 9783319067124

SP - 129

EP - 176

BT - Sickle Cell Anemia

PB - Springer International Publishing

ER -